Key result
Atrial fibrillation is a common and complex arrhythmia affecting nearly 2.5 million Americans and contributing to roughly 15 percent of strokes in the United States.
Highlights the growing prevalence and clinical impact of atrial fibrillation, emphasizing its complex pathogenesis involving connexins and conduction.
Atrial fibrillation has always been the little sister to its ventricular counterpart — but during the past decade, it has captured our attention, mainly because it is so common. Atrial fibrillation affects nearly 2.5 million Americans, and this number could double over the next 50 years as the population ages.1 Although not the killer that ventricular fibrillation is, atrial fibrillation is by no means benign. Roughly 15 percent of strokes in the United States have been attributed to this arrhythmia.2 The pathogenesis of atrial fibrillation is complex, even as compared with the other tachyarrhythmias. Atrial fibrillation arises from dynamic interactions . . .
No takes yet. Share an insight, caveat, or question.
Jeffrey E. Saffitz (2006) conducted an editorial in Atrial fibrillation. Atrial fibrillation is a common and complex arrhythmia affecting nearly 2.5 million Americans and contributing to roughly 15 percent of strokes in the United States.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: